Skip to main content

Table 2 Clinical and microbiological characteristics of ESBL-producing hvKp isolates

From: Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor

Clinical characteristic

P14

P32

P34

P45

P51

P65

P92

P133

P145

P212

P221

P233

P237

Age

 

86

73

89

90

94

79

85

86

93

91

93

86

Gender

M

M

M

M

M

M

M

M

M

M

M

M

M

Clinical department

Cardiology

ICU

Urology

CCU

Respiratory

ICU

Endocrinology

Respiratory

Gastroenterology

ICU

Cardiology

Respiratory

CCU

Date of specimen (yr/mo/day)

2011/04/18

2010/10/10

2010/07/14

2008/10/24

2008/07/22

2010/10/14

2011/08/11

2011/07/11

2013/05/19

2014/01/21

2013/05/15

2013/09/11

2013/01/16

Main underlying diseases

Cardiovascular diseases

UIP

Prostate Disease

CHD

Bronchiectasis

Diabetes

Diabetes

UIP

Diabetes

UIP

Heart failure

Diabetes

Diabetes

Tube

CVC; ureter; stomach tube

CVC; ureter; stomach tube; tracheal catheter

CVC; ureter; stomach tube; tracheal catheter

CVC; ureter; stomach tube

Ureter; stomach tube

CVC; ureter; stomach tube; Tracheal catheter

CVC; ureter; stomach tube; tracheal catheter

Non

Non

CVC; ureter; stomach tube; tracheal catheter

CVC; ureter; stomach tube

Stomach tube

Stomach tube

Specimen type

Sputum

Sputum

Urine

Urine

Sputum

Sputum

Sputum

Sputum

Sputum

Sputum + blood

Urine

Sputum

Sputum

Infection type

Pneumonia

Sepsis

Sepsis

Urinary infection

Pneumonia

Sepsis

Sepsis

Pneumonia

Pneumonia

Sepsis shock

Urinary infection

Pneumonia

Pneumonia

WBC (109/L)

14.36

11.35

13.14

7.33

8.34

7.38

13.2

8.47

12.26

14.1

8.3

9.45

13.3

NEU (%)

82.9

87.6

81.3

69.2

67.5

66.3

83.1

70.5

78.3

64.4

69.3

81.3

76.3

TP (g/L)

67

63.7

75

61

58

60

61

69

68

61

64

62

67

ALB (g/L)

35.2

30.7

35.7

34.5

31.3

31.5

32.9

39

36.9

32.6

37.2

36.5

37.8

MDR

Y

Y

Y

Y

Y

Y

Y

N

N

Y

Y

Y

N

Antibiotic resistance type

Penicillins; cephalosporins; aminoglycosides; beta-lactamase inhibitor; quinolones

Penicillins; cephalosporins; aminoglycosides

Penicillins; cephalosporins; sulfonamides

Penicillins; cephalosporins; aminoglycosides

Penicillins; cephalosporins; aminoglycosides; beta-lactamase inhibitor; quinolones; Sulfonamides

Penicillins; cephalosporins; aminoglycosides; beta-lactamase inhibitor; quinolones; Sulfonamides

Penicillins; cephalosporins; quinolones

Penicillins; cephalosporins;

Penicillins; cephalosporins

Penicillins; cephalosporins; aminoglycosides

Penicillins; cephalosporins; aminoglycosides

Penicillins; cephalosporins; sulfonamides

Penicillins; cephalosporins

Empiric Therapy

CIP + CAZ

MEM + ISE

CMZ

IPM

MXF

CIP + CAZ

IPM + ISE

MXF

MXF

TZP + ISE

MXF

CIP + CAZ

CIP + CAZ

Switched Therapy

MEM

MEM

MXF

TZP

MEM

CAZ + TZP

IPM

MXF

MXF

MEM + CIP

MXF

CIP + ISE

CIP + ISE

SOFA score

6

7

10

3

5

7

8

3

5

11

5

7

6

Clinical outcome

Survived

Survived

Survived

Survived

Survived

Survived

Survived

Survived

Survived

Died

Survived

Survived

Survived

String test length (mm)

100

30

50

100

40

20

200

45

20

60

8

8

50

Virulence-associated genes

             

rmpA

+

+

+

+

+

+

+

+

rmpA2

+

+

+

+

+

+

+

magA

+

+

+

+

+

+

+

+

+

+

+

+

aerobactin

+

+

+

+

+

+

+

+

+

+

+

+

+

cps genes

             

K1

+

+

K2

K5

K20

K54

K57

+

MLST genotyping

2899

2892

34

2888

1264

412

2898

2920

23

17

2836

101

23

Clone complex

Singleton

CC292

CC34

CC1

CC11

CC412

CC1

singleton

CC23

CC17

CC292

CC101

CC23

  1. M male, ICU intensive care unit, CCU coronary care unit, UIP usual interstitial pneumonia, CHD coronary heart disease, CVC central venous catheter, CIP ciprofloxacin, MEM meropenem, IPM imipenem, TZP piperacillin tazobactam, ISE isepamicin, CMZ cefmetazole, MXF moxifloxacin, CAZ ceftazidime, Y yes, N no